ReviewCureus2026
Comparing Cardiovascular Morbidity and Mortality in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy Versus Sustained Low-Efficiency Dialysis: A Systematic Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This systematic review evaluated the comparative effectiveness of continuous renal replacement therapy and sustained low-efficiency dialysis in critically ill adults with acute kidney injury, with a particular focus on hemodynamic and cardiovascular outcomes. A comprehensive literature search across major databases identified six eligible studies, including one randomized controlled trial, one randomized crossover trial, and four observational cohorts. Across these studies, mortality outcomes were similar between modalities, with no evidence of a survival advantage for continuous renal replacement therapy. Hemodynamic results were likewise comparable, as both therapies maintained stable mean arterial pressure, demonstrated parallel Sequential Organ Failure Assessment (SOFA) score trends, and showed no meaningful differences in vasopressor needs or cardiovascular stress markers. Some studies reported modest improvements in hemodynamic tolerance and fewer circuit-related complications with sustained low-efficiency dialysis, reflecting potential practical benefits in daily intensive care unit practice. Despite variability in study designs and heterogeneity in dialysis protocols, the overall evidence suggests that sustained low-efficiency dialysis offers a safe and effective alternative to continuous renal replacement therapy, particularly in resource-limited settings where logistical or operational constraints may influence modality choice. Further large, standardized trials are needed to refine patient-centered modality selection and to better characterize long-term cardiovascular outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.